Sanofi-aventis and JDRF Form Partnership to Improve Therapies
- Details
- Category: Sanofi

Phase III study shows Novartis drug Afinitor® more than doubles time without tumor growth
- Details
- Category: Novartis

Shire Purchases Strategic Site in Massachusetts
- Details
- Category: Shire

Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections
- Details
- Category: Merck

AstraZeneca and MMV Join Efforts in the Fight Against Malaria
- Details
- Category: AstraZeneca

Victoza® (liraglutide) provided superior and sustained blood sugar control and weight reduction
- Details
- Category: Novo Nordisk

ONGLYZA (saxagliptin) with Metformin as Initial Combination Therapy
- Details
- Category: Bristol-Myers Squibb

More Pharma News ...
- Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program
- AstraZeneca and Targacept Initiate Phase 3 Clinical Development of TC-5214
- 34 Teachers and Schools Across North America Receive $10,000 Amgen Award
- New SIMPONI (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis
- FDA approves Tasigna® for newly diagnosed chronic myeloid leukemia patients
- RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis
- Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance